PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer

Novartis Pluvicto Delays Progression to End-Stage Prostate Cancer According to PSMAddition data, Novartis Pluvicto has shown to delay progression to end-stage prostate cancer. Abou…